ENSCW (ENSCW)
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Market Cap
—
P/E (TTM)
—
EPS
—
Div Yield
—
52W Range
—
Beta
—
Company overview
Live quote temporarily unavailable — press releases and news are still shown below.
No company overview is available for ENSCW yet.
Peers in industry
ENSCW has no peer companies in this window.
Recent press releases
March 2026
4 months ago8-K
Ensysce Biosciences, Inc. — 8-K Filing
ENSCWEnsysce Biosciences, Inc.
# 🧾 What This Document Is This is an **earnings release** from Ensysce Biosciences, announced on March 30, 2026. It’s like a company’s quarterly report card, showing how they did financially and operationally for the final three months (Q4) and all of 2025. It also updates investors on the progress
Read summaryView on SEC EDGAR
SEC filings
All filings →1 recent filing shown in the timeline above. View all SEC filings →
Insider trades
All insider trades →ENSCW has no reported insider trades in the last 90 days.
Institutional holders
All holders →As of 2025-12-31 · prior 2025-09-30
PERCEPTIVE ADVISORS LLC$79,733
86,666 sh0.0%
DRW Securities, LLC$90,602
98,481 sh+42.4%
VANGUARD GROUP INC$33,772
36,708 sh0.0%
149,711 sh+100.4%
Financial Plan, Inc.$22,080
24,000 sh● NEW
TWO SIGMA SECURITIES, LLC$19,877
21,605 sh● NEW
Williams & Novak, LLC$16,422
17,850 sh● NEW
12,000 sh+14.3%
People at ENSCW
All people →No officers or directors have been indexed for ENSCW.
Quarterly financials
Full financials →Revenue trend
03/25
$1.3M
NI —
06/25
$1.4M
NI —
09/25
$493.1K
NI —
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-1.29
Prior: $-0.79
Revenue sparkline